Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Roger N. Pearse"'
Autor:
Mateo Mejia Saldarriaga, Walaa Darwiche, David Jayabalan, Jorge Monge, Cara Rosenbaum, Roger N. Pearse, Ruben Niesvizky, Mark Bustoros
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Recent insight in the genomic landscape of newly diagnosed multiple myeloma (NDMM) and its precursor conditions, monoclonal gammopathy of uncertain significance (MGUS), and smoldering myeloma have allowed the identification of patients with precursor
Externí odkaz:
https://doaj.org/article/3cbfd49d5d464b6db6efc7e67308993a
Autor:
Ola Landgren, Gareth J. Morgan, Suzanne Lentzsch, Ruben Niesvizky, Sundar Jagannath, Faith E. Davies, Ying Taur, Ran Reshef, Christian Gordillo, Marc J. Braunstein, David Kaminetzky, Ajai Chari, Deepu Madduri, Roger N. Pearse, Adriana Rossi, Benjamin Diamond, Andriy Derkach, Francesco Maura, Carlyn Tan, Hani Hassoun, Alexander M. Lesokhin, Urvi A. Shah, Sham Mailankody, Sydney X. Lu, Neha Korde, Eric L. Smith, Dhwani Patel, Cara A. Rosenbaum, Joshua Richter, Malin Hultcrantz
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53454f0abd907aba2e1ad9eb141d8e39
https://doi.org/10.1158/2643-3230.22542939
https://doi.org/10.1158/2643-3230.22542939
Autor:
Ola Landgren, Gareth J. Morgan, Suzanne Lentzsch, Ruben Niesvizky, Sundar Jagannath, Faith E. Davies, Ying Taur, Ran Reshef, Christian Gordillo, Marc J. Braunstein, David Kaminetzky, Ajai Chari, Deepu Madduri, Roger N. Pearse, Adriana Rossi, Benjamin Diamond, Andriy Derkach, Francesco Maura, Carlyn Tan, Hani Hassoun, Alexander M. Lesokhin, Urvi A. Shah, Sham Mailankody, Sydney X. Lu, Neha Korde, Eric L. Smith, Dhwani Patel, Cara A. Rosenbaum, Joshua Richter, Malin Hultcrantz
Patients with multiple myeloma have a compromised immune system, due to both the disease and antimyeloma therapies, and may therefore be particularly susceptible to COVID-19. Here, we report outcomes and risk factors for serious disease in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc094855f250432258fa025fb0580e50
https://doi.org/10.1158/2643-3230.c.6550092
https://doi.org/10.1158/2643-3230.c.6550092
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 58K, Study design and patient flow by intent to treat (ITT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ea303679dbde4a3397e161607c8dd5
https://doi.org/10.1158/1078-0432.22451307.v1
https://doi.org/10.1158/1078-0432.22451307.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 53K, Validation of gene expression data using QPCR compared to microarray values (data reported as fold change).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cd424e4842520d88c910511e4e34e30
https://doi.org/10.1158/1078-0432.22451295.v1
https://doi.org/10.1158/1078-0432.22451295.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
Purpose: This phase II study evaluated bortezomib-based secondary induction and stem cell mobilization in 38 transplant-eligible patients with myeloma who had an incomplete and stalled response to, or had relapsed after, previous immunomodulatory dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::414ec225af4e68b8b1d603e092292a1b
https://doi.org/10.1158/1078-0432.c.6522156.v1
https://doi.org/10.1158/1078-0432.c.6522156.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 72K, Most common all-grade and grade ≥3 AEs during DoVeD induction and bortezomib-based stem cell mobilization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7f101e675536a36b8d8b71fb9facd94
https://doi.org/10.1158/1078-0432.22451298.v1
https://doi.org/10.1158/1078-0432.22451298.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 60K, Kaplan-Meier estimates of (A)PFS and (B)OS in patients in the ITT population (N-38).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::716900104ac92767fb80db3b5a0ea5ec
https://doi.org/10.1158/1078-0432.22451304.v1
https://doi.org/10.1158/1078-0432.22451304.v1
Autor:
Maureen E. Lane, Morton Coleman, Selina Chen-Kiang, Donna Skerret, Scott Ely, Zhaoying Xiang, Karen Pekle, Faiza Zafar, Tsiporah B. Shore, Lena Mathews, Paul J. Christos, Jessica Stern, Megan Manco, Roger N. Pearse, David S. Jayabalan, Maureen Ward, Tomer M. Mark, Ruben Niesvizky
PDF file - 59K, Responses rates after DoVeD induction, bortezomib- or non-bortezomib-based mobilization, and SCT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c621610cc5e6613eab92573e28d9b55
https://doi.org/10.1158/1078-0432.22451301
https://doi.org/10.1158/1078-0432.22451301
Autor:
Adomah Opong, June Greenberg, Richard R. Furman, Adriana C Rossi, Michelle Pasciolla, Koen van Besien, Adrienne A. Phillips, Yuliya S. Jhanwar, Usama Gergis, Tsiporah B. Shore, Peter Martin, Tomer M Mark, John P. Leonard, Grace Suhu, Sarah C. Rutherford, Kathleen Maignan, Sebastian Mayer, Jessy Ryan, Danielle Guarneri, Roger N. Pearse, Calvin Koo, Jia Ruan, Maria Baldo, Jingmei Hsu, Edwidge Cuvilly, Nina Orfali
Publikováno v:
Leukemia & Lymphoma. 62:1629-1638
We evaluate the safety of bendamustine as a bridge to stem cell transplantation (SCT) in patients with relapsed/refractory lymphoma and residual disease after salvage therapy. Thirty-four subjects without complete responses (CR) received bendamustine